EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction in Patients With Multiple Sclerosis: A Pilot Trial

Hanne Kobberø iD, Jan Krhut iD, Peter Zvara iD, Torben Brøchner Pedersen iD, Mikkel Fode iD, Helle Hvilsted Nielsen iD, Mads Hvid Poulsen iD

Neurourology and Urodynamics · 2025

DOI: 10.1002/nau.70052 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Hanne Kobberø und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Multiple Sclerosis, Electric Stimulation Therapy, Urinary Bladder, Neurogenic, Sexual Dysfunction, Physiological. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This trial was funded by the Multiple Sclerosis Association, Denmark, The Department of Urology, Odense University Hospital, Faculty scholarship, the Universit….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We present results of a two‐arm pilot study assessing the feasibility of conducting a double‐blind randomized controlled trial (RCT) to evaluate the efficacy of sacral neuromodulation (SNM) in patients with multiple sclerosis (MS) suffering from neurogenic lower urinary tract dysfunction (NLUTD).

Methods

Eligible subjects with refractory NLUTD and EDSS < 5 underwent SNM test phase. Those showing more than a 50% improvement of bladder variables, received implantable pulse generators (IPG) and were randomized to either treatment group (IPG ON) or to sham group (IPG OFF) for 1 month. During second month, all patients had the IPG ON until the end of the trial. The primary endpoints were trial feasibility, recruitment potential, and response rate at the end of SNM test phase. Secondary endpoint was safety. Changes in key bladder diary‐derived variables and patient reported outcomes were recorded as well.

Results

Thirty‐two patients were screened, 17 were eligible and 13 were included in the SNM test phase. Eleven were considered responders and were implanted with IPG. Subsequently, six patients were randomized to the treatment group and five to the sham group. No serious adverse events were reported. In the intervention phase, both objective and subjective improvements were seen in the treatment group, while the symptoms in the sham group remained mostly unchanged. At study completion, six patients reported being completely satisfied, three were mostly satisfied, and two were indifferent to the treatment.

Conclusions

This pilot trial demonstrated feasibility of double‐blind RCT assessing safety and efficacy of SNM in MS patients.

Trial registration

ClinicalTrials.gov NCT05380856.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisElectric Stimulation TherapyUrinary Bladder, NeurogenicSexual Dysfunction, PhysiologicalLower Urinary Tract SymptomsHumansPilot ProjectsFemaleMaleDouble-Blind MethodAdultMiddle AgedTreatment OutcomeFeasibility StudiesLumbosacral Plexus

Stichwörter der Autor:innen

bowel dysfunctionmultiple sclerosisneurogenic lower urinary tract dysfunctionneurourologysacral neuromodulationsexual dysfunction

Autor:innen und Institutionen

  • Department of Urology, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, Research Unit of Urology, University of Southern Denmark, Odense, Denmark.
  • Department of Urology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Department of Surgical Studies, Ostrava University, Ostrava, Czech Republic.
  • Department of Urology, Copenhagen University Hospital - Herlev and Gentofte Hospital, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Hanne Kobberø, Jan Krhut, Peter Zvara, Torben Brøchner Pedersen, Mikkel Fode, Helle Hvilsted Nielsen, Mads Hvid Poulsen

Förderung

  • This trial was funded by the Multiple Sclerosis Association, Denmark, The Department of Urology, Odense University Hospital, Faculty scholarship, the Universit…

Zitieren

APA

Kobberø, H., Krhut, J., Zvara, P., Pedersen, T. B., Fode, M., Nielsen, H. H., & Poulsen, M. H. (2025). Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction in Patients With Multiple Sclerosis: A Pilot Trial. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70052

Vancouver

Kobberø H, Krhut J, Zvara P, Pedersen TB, Fode M, Nielsen HH, et al. Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction in Patients With Multiple Sclerosis: A Pilot Trial. Neurourology and Urodynamics. 2025. doi:10.1002/nau.70052

BibTeX
@article{Kobber2025,
  author = {Kobberø, Hanne and Krhut, Jan and Zvara, Peter and Pedersen, Torben Brøchner and Fode, Mikkel and Nielsen, Helle Hvilsted and Poulsen, Mads Hvid},
  title = {Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction in Patients With Multiple Sclerosis: A Pilot Trial},
  journal = {Neurourology and Urodynamics},
  year = {2025},
  doi = {10.1002/nau.70052}
}
Kostenlos starten →